Government Partnering
ABL has supported the US Government’s mission to prevent, treat, and diagnose infectious diseases for over 60 years. Today, we are managing contracts with that same mission with greater than $1B in potential value.
We act as a translational solutions integrator to support biotechnology product development including vaccines, medical countermeasures, as well as therapeutics against infectious disease, cancer, neurological disorders and other indications.
Our approach is to be a translational solutions integrator providing the following expertise:
Subject Matter Experience
Quality Oversight
Government Contracting
Project Management
Financial Management
Subcontractor Management
ABL provides scientific and contractual expertise to navigate government and NGO funding opportunities for our clients.
ABL can serve as a prime or subcontractor on new opportunities from NIH, BARDA, DOD, ARPA-H, CDC and NGO's such as the Bill and Melinda Gates Foundation and the Wellcome Trust.
Government opportunities we support
Broad Agency Announcements
IDIQ Contracts
Small Business Grants/Contracts
Program Project Grants
Grants that Require an Industrial Partner
Contact Us for Other Opportunities
Proud to be a member of
Our Product Development Collaboratory enables ABL to act as a virtual biologic CDMO that can provide the breadth of services necessary to bring ANY biological innovation to the clinic.
Over 50 vendors in the US and Europe participate in the ABL Collaboratory.
Any Substrate Platform
- Mammalian
- Insect
- Avian
- Yeast
- Microbial
- Plant
- Synthetic
- Suspension
- Adherenti
Any Development Service
- Product Development Plans
- Technology Transfer
- Cell Line Development
- Process Innovation
- Process Development
- Analytical Development
- GMP Manufacture
- Formulation, Dosage Form, Lyophilization
- Safety/Toxicology Testing
- Efficacy Testing
- ADME, pK/pD studies
- Bioassay development
- Fill/Finish
- Release & Stability Testing
- Regulatory Strategy
Any Biologic Product Type
- Vaccines (subunit, RNA/DNA, Viral, etc.)
- Oligonucleotides (ASO, siRNA, etc)
- Gene Delivery
- Antibody-based Biologics
- Peptides
- Cell-based Therapy (iPSC, CAR-T, exosomes, etc.)
- Gene-editing technology
- Formulations (liposomes, micelles, metallic nanoparticles, etc.)
- Multipurpose Prevention Technology
Together, we will use science to drive solutions.
Contact us at info@ablinc.com
